What does Geassocieerde Apotheek Merksem do?

Geassocieerde Apotheek Merksem is a pharmacy in Antwerpen. Private Limited, started on 25 June 2007, 1 establishment.

What is the address of Geassocieerde Apotheek Merksem?

The registered office of Geassocieerde Apotheek Merksem is located at Weggestraat 5, 2170 Antwerpen.

Is Geassocieerde Apotheek Merksem still active?

Yes. According to the CBE (29 October 2026) Geassocieerde Apotheek Merksem is active, legal situation “Normale toestand”, started on 25 June 2007.

Is Geassocieerde Apotheek Merksem registered on Peppol?

Yes, Geassocieerde Apotheek Merksem is registered on the Peppol network with ID 0208:0890315983.

What is the enterprise number of Geassocieerde Apotheek Merksem?

The enterprise number of Geassocieerde Apotheek Merksem is BE0890315983.

When was Geassocieerde Apotheek Merksem founded?

Geassocieerde Apotheek Merksem was founded on 25 June 2007.

Who are the directors of Geassocieerde Apotheek Merksem?

According to the 2025 annual accounts, the directors of Geassocieerde Apotheek Merksem are: A. Pirlot, J. Mannaerts.

Is Geassocieerde Apotheek Merksem a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 June 2007; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Geassocieerde Apotheek Merksem make in 2025?

Geassocieerde Apotheek Merksem posted a profit after taxes of € 27,482 in financial year 2025.

What is the revenue of Geassocieerde Apotheek Merksem?

As a small company, Geassocieerde Apotheek Merksem is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 191,125.

How much does an employee at Geassocieerde Apotheek Merksem earn?

The average wage cost per full-time employee at Geassocieerde Apotheek Merksem was € 77,000 in 2025: staff costs of € 153,965 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Geassocieerde Apotheek Merksem have?

According to the 2025 annual accounts, Geassocieerde Apotheek Merksem has 2 full-time equivalents (FTE).

Geassocieerde Apotheek Merksem (Private Limited)

Dossier Geassocieerde Apotheek Merksem, printed on 29 October 2026 from databakkes.be/en/0890315983/geassocieerde-apotheek-merksem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Geassocieerde Apotheek Merksem from Antwerpen, company number BE0890315983, closed financial year 2025 with a result of € 27,482 after tax. For that financial year Geassocieerde Apotheek Merksem recorded a gross margin of € 191,125 and equity of € 490,387. Compared with financial year 2024, the result moved from € 33,144 to € 27,482. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Growing

€ 490,387

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 27,482

▼ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 9,177

▲ 74% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 470,387.

People and assets in 2025

Full-time equivalents

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 153,965

▲ 14% vs 2024

€ 77,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 2,862

▼ 15% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 101,727

▲ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,942

▼ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 208,352 Gross margin 2022: € 208,352 First fiscal year in the series	€ 156,893 Gross margin 2023: € 156,893 ▼ 25% vs 2022 (€ 208,352) Unfavourable step	€ 187,080 Gross margin 2024: € 187,080 ▲ 19% vs 2023 (€ 156,893) Favourable step	€ 191,125 Gross margin 2025: € 191,125 ▲ 2% vs 2024 (€ 187,080) Favourable step	▲ 2%
Profit after taxes	€ 53,355 Profit after taxes 2022: € 53,355 First fiscal year in the series	€ 47,240 Profit after taxes 2023: € 47,240 ▼ 11% vs 2022 (€ 53,355) Unfavourable step	€ 33,144 Profit after taxes 2024: € 33,144 ▼ 30% vs 2023 (€ 47,240) Unfavourable step	€ 27,482 Profit after taxes 2025: € 27,482 ▼ 17% vs 2024 (€ 33,144) Unfavourable step	▼ 17%
Equity	€ 382,520 Equity 2022: € 382,520 First fiscal year in the series	€ 429,761 Equity 2023: € 429,761 ▲ 12% vs 2022 (€ 382,520) Favourable step	€ 462,905 Equity 2024: € 462,905 ▲ 8% vs 2023 (€ 429,761) Favourable step	€ 490,387 Equity 2025: € 490,387 ▲ 6% vs 2024 (€ 462,905) Favourable step	▲ 6%
Total debts	€ 201,962 Total debts 2022: € 201,962 First fiscal year in the series	€ 181,477 Total debts 2023: € 181,477 ▼ 10% vs 2022 (€ 201,962) Favourable step	€ 110,036 Total debts 2024: € 110,036 ▼ 39% vs 2023 (€ 181,477) Favourable step	€ 133,531 Total debts 2025: € 133,531 ▲ 21% vs 2024 (€ 110,036) Unfavourable step	▲ 21%
Cash	€ 53,400 Cash 2022: € 53,400 First fiscal year in the series	€ 54,647 Cash 2023: € 54,647 ▲ 2% vs 2022 (€ 53,400) Favourable step	€ 5,270 Cash 2024: € 5,270 ▼ 90% vs 2023 (€ 54,647) Unfavourable step	€ 9,177 Cash 2025: € 9,177 ▲ 74% vs 2024 (€ 5,270) Favourable step	▲ 74%
Retained profit	€ 362,520 Retained profit 2022: € 362,520 First fiscal year in the series	€ 409,761 Retained profit 2023: € 409,761 ▲ 13% vs 2022 (€ 362,520) Favourable step	€ 442,905 Retained profit 2024: € 442,905 ▲ 8% vs 2023 (€ 409,761) Favourable step	€ 470,387 Retained profit 2025: € 470,387 ▲ 6% vs 2024 (€ 442,905) Favourable step	▲ 6%
Bank debt	€ 4,875 Bank debt 2022: € 4,875 First fiscal year in the series	€ 2,375 Bank debt 2023: € 2,375 ▼ 51% vs 2022 (€ 4,875) Favourable step	€ 3,375 Bank debt 2024: € 3,375 ▲ 42% vs 2023 (€ 2,375) Unfavourable step	€ 2,862 Bank debt 2025: € 2,862 ▼ 15% vs 2024 (€ 3,375) Favourable step	▼ 15%
Balance sheet total	€ 584,482 Balance sheet total 2022: € 584,482 First fiscal year in the series	€ 611,238 Balance sheet total 2023: € 611,238 ▲ 5% vs 2022 (€ 584,482) Unchanged	€ 572,942 Balance sheet total 2024: € 572,942 ▼ 6% vs 2023 (€ 611,238) Unchanged	€ 623,918 Balance sheet total 2025: € 623,918 ▲ 9% vs 2024 (€ 572,942) Unchanged	▲ 9%
Employees (FTE)	2 Employees (FTE) 2022: 2 First fiscal year in the series	2 Employees (FTE) 2023: 2 Unchanged (2) Unchanged	1.9 Employees (FTE) 2024: 1.9 ▼ 0.1 vs 2023 (2) Unchanged	2 Employees (FTE) 2025: 2 ▲ 0.1 vs 2024 (1.9) Unchanged	▲ 0.1

Key figures of Geassocieerde Apotheek Merksem, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Geassocieerde Apotheek Merksem?

What happened at Geassocieerde Apotheek Merksem in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 A. Pirlot stepped down as director. NBB
2029 J. Mannaerts stepped down as director. NBB
Jul 28, 2026 New annual accounts for financial year 2025: profit of € 27,482 (▼ 17% vs 2024). Source: NBB ↗
2025 A. Pirlot became a director. NBB
2023 J. Mannaerts became a director. NBB
Jul 2, 2007 New establishment in Antwerpen. KBO
Jun 25, 2007 Start of the company according to the CBE. KBO

In short

From € 53,355 profit in 2022 to € 27,482 profit in 2025.

Paid € 56,976 in corporate taxes since 2022.

Best year ever: 2022, with € 53,355 profit.

On average € 95,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

APOTHEEK DE KROON 98%

AFS 1%

GEASSOCIEERDE APOTHEEK MARKGRAVE 1%

The stake of APOTHEEK DE KROON, AFS, GEASSOCIEERDE APOTHEEK MARKGRAVE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Geassocieerde Apotheek Merksem

AFS 2.7%

The shares are held by APOTHEEK DE KROON (98%), AFS (1%) and GEASSOCIEERDE APOTHEEK MARKGRAVE (1%). It owns 2.7% of AFS itself.

Directors

According to the 2025 annual accounts

A. Pirlot

Director

Also active at: Apoteek't Groen Kruis, Sint-Gummarus Apotheek, AFS, Apotheek Clessens, Antwerp Port Pharmacy, APOTHEEK VAN BROEKHOVEN, GEASSOCIEERDE APOTHEEK EKEREN, GEASSOCIEERDE APOTHEEK VAN PUYVELDE +9 more

since 2025 · until 2031

J. Mannaerts

Director

Also active at: Geassocieerde Apotheek Plantijn, AFS, Apotheek Clessens, Antwerp Port Pharmacy, APOTHEEK VAN BROEKHOVEN, GEASSOCIEERDE APOTHEEK EKEREN, GEASSOCIEERDE APOTHEEK VAN PUYVELDE, GEASSOCIEERDE APOTHEEK VERBIST +7 more

since 2023 · until 2029

Shareholders

APOTHEEK DE KROON

98%

AFS

GEASSOCIEERDE APOTHEEK MARKGRAVE

Participations

AFS

2.7%

Establishments

Establishment units

Physical locations of this company

Registered office

Weggestraat 5

2170 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0890.315.983

VAT number

BE 0890.315.983

Registered office

Weggestraat 5, 2170 Antwerpen

Names & denominations

Geassocieerde Apotheek Merksem · G.A. MERKSEM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

25 June 2007

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗